Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection

Coronavirus disease 2019 (Covid-19) caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) became a pandemic, causing significant burden on public health worldwide. Although the timely development and production of mRNA and adenoviral vector vaccines against SARS-CoV-2 have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Deok-Hwan, Lee, Jiho, Youk, Sungsu, Jeong, Jei-hyun, Lee, Da-ye, Ju, Hyo-seon, Youn, Ha-na, Kim, Jin-cheol, Park, Soo-bin, Park, Ji-eun, Kim, Ji-yun, Kim, Tae-hyeon, Lee, Seung-hun, Lee, Hyukchae, Mouhamed Abdallah Amal Abdal, Lah, Lee, Dong-Hun, Park, Pil-Gu, Hong, Kee-Jong, Song, Chang-Seon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266497/
https://www.ncbi.nlm.nih.gov/pubmed/37355454
http://dx.doi.org/10.1016/j.vaccine.2023.05.071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266497/
https://www.ncbi.nlm.nih.gov/pubmed/37355454
http://dx.doi.org/10.1016/j.vaccine.2023.05.071

Ejemplares similares